Vivace Therapeutics is based in San Francisco Bay Area. It has raised $105M in total funding. Latest round: Series D.
Vivace Therapeutics is based in San Francisco Bay Area. Vivace Therapeutics has raised $105M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series D announced in February 2025. The round record for Vivace Therapeutics runs through 2025; nothing later has been disclosed. Investors on record include RA Capital Management, Cenova Capital, Canaan Partners, WuXi Healthcare Ventures, Sequoia Capital China, Boxer Capital. 6 distinct backers are named across the disclosed rounds.
Round data for Vivace Therapeutics is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in San Francisco Bay Area and backer lists below.
Company funding database · Investor directory · Founder database · Mega-rounds 2026